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Abstract: The potential of eccrine sweat as a bio-fluid of interest for diagnosis and personalized
therapy has not yet been fully evaluated, due to the lack of in-depth sweat characterization studies.
Thanks to recent developments in omics, together with the availability of accredited sweat collection
methods, the analysis of human sweat may now be envisioned as a standardized, non-invasive
test for individualized monitoring and personalized medicine. Here, we characterized individual
sweat samples, collected from 28 healthy adult volunteers under the most standardized sampling
methodology, by applying optimized shotgun proteomics. The thorough characterization of the sweat
proteome allowed the identification of 983 unique proteins from which 344 were identified across
all samples. Annotation-wise, the study of the sweat proteome unveiled the over-representation of
newly addressed actin dynamics, oxidative stress and proteasome-related functions, in addition to
well-described proteolysis and anti-microbial immunity. The sweat proteome composition correlated
with the inter-individual variability of sweat secretion parameters. In addition, both gender-exclusive
proteins and gender-specific protein abundances were highlighted, despite the high similarity be-
tween human female and male sweat proteomes. In conclusion, standardized sample collection
coupled with optimized shotgun proteomics significantly improved the depth of sweat proteome
coverage, far beyond previous similar studies. The identified proteins were involved in many diverse
biological processes and molecular functions, indicating the potential of this bio-fluid as a valuable
biological matrix for further studies. Addressing sweat variability, our results prove the proteomic
profiling of sweat to be a promising bio-fluid analysis for individualized, non-invasive monitoring
and personalized medicine.
Keywords: human eccrine sweat; shotgun proteomics; inter-individual variability
1. Introduction
Sweat is secreted by millions of eccrine glands ubiquitously distributed over the
human skin surface and involved in body thermoregulation by evaporation and skin
homeostasis (hydration and immunity) [1,2]. Eccrine glands secrete a hypotonic solution
of water-soluble electrolytes, e.g., sodium, chloride, potassium, urea or lactate and non-
electrolytes, i.e., proteins, anti-microbial peptides and metabolites [3–6]. In clinical routine,
investigations of sweat composition are limited to the determination of drug intake and
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the diagnosis of cystic fibrosis based on the measurement of sweat chloride concentration
(Gibson and Cooke sweat test) [7,8].
Eccrine sweat is a promising bio-fluid of interest in the field of personalized medicine
thanks to its less invasive collection relative to its complex composition, representing a
valuable source of information [9] when compared to other routine bio-fluids such as
bronchoalveolar, synovial or cerebrospinal fluids. In addition, the recent developments
of high-resolution and high-sensitivity analytical techniques now allow working with
small sweat volumes (10–20 µL) collected from standardized methods. Up to now, few
proteomic studies have been conducted on eccrine sweat [10–13]. Despite the lower
protein concentration (0.1–1 mg/mL), reports highlighted sweat as a likely informative
source of biomarkers for monitoring both physiological and pathophysiological conditions;
for example, disease-specific profiles of sweat proteins were described in patients with
schizophrenia or tuberculosis [14,15]. However, all previous works were carried out on
pooled sweat samples, thereby missing the inter-individual spectrum of sweat proteome
variability.
In order to use sweat as a bio-fluid of interest, one must be able to characterize
reference physiological profiles and inter-individual variations under steady-state con-
ditions with standardized reproducible methods to discriminate between physiological
responses to stimuli or disease-induced alterations. Eccrine sweat composition was de-
scribed as complex and highly variable under normal physiological conditions, depending
on multiple levels of stimulation and regulation, mechanisms of secretion and tissue contri-
butions [16,17]. This complexity reflects the diversity of sweat’s biological functions, but it
is also a major source of intra- and inter-individual variability.
In the context of personalized medicine, in light of the potential of eccrine sweat as a
relevant source of protein biomarkers for prognosis or diagnosis of disease conditions and
clinical follow-up, the current work was designed to carry out an in-depth characterization
of the eccrine sweat proteome of healthy subjects. To this end, we applied standardized
reproducible sweat collection, sample preparation, LC–MS/MS (liquid chromatography-
tandem mass spectrometry) analysis and MS (mass spectrometry) data processing to
the proteomic profiling of eccrine sweat. Nine hundred and eighty-three proteins were
identified and quantified by a label-free approach across 28 individual samples, a significant
improvement when compared to previous similar studies. Proteome annotation tackled
newly described biological functions of sweat proteins and elaborated on the composition
of sweat in terms of tissue contributions. In addition, the present study concluded on the
effect of sweat rate on the inter-individual variability of sweat protein profiles and on the
limited but significant influence of gender.
2. Materials and Methods
2.1. Sweat Collection
Sweat samples were collected from 30 healthy volunteers (HV, 15 female, 15 male)
under the most standardized and spectroscopically pure conditions following the current
recommendations for the Gibson and Cooke sweat test [18]. In brief, the volar region
of both forearms was chosen based on its high density of eccrine sweat glands together
with its very low density of apocrine/apoeccrine sweat glands and its easy access. Sweat
samples were collected from each forearm successively, from fasting and well-hydrated
individuals. Before sweat sampling, the tested skin region was washed with 70% ethanol,
rinsed with ultrapure water and dried using ashless filter paper. Eccrine sweat secretion
was stimulated by pilocarpine iontophoresis using pilocarpine gel-padded (Pilogel® discs,
ELITechGroup, Brussels, Belgium) electrodes: a 5 mA current (Webster Sweat Inducer,
Model 3700, ELITechGroup, Brussels, Belgium) was applied for 5 min. After stimulation,
the electrodes were removed and a Macroduct Sweat Collector (ELITechGroup, Brussels,
Belgium) (blue dye removed with 70% ethanol and ashless filter paper) was attached in the
place of the cathode to collect pure, non-diluted, pressure-driven eccrine sweat for 30 min.
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At the end of the collection time, the collector tubing was uncoiled, cut off and connected
to a needle and syringe to transfer sweat to a 0.6 mL micro-tube.
2.2. Sample Preparation for Shotgun Proteomics
Pure, undiluted sweat samples were processed in three series of ten individual samples.
Three sample preparation rounds (1 per series) were performed to avoid any technical bias
that might come from a single sample preparation experiment
Sweat protein concentration was estimated using the Pierce Micro BCA™ Protein
Assay kit (#23235, ThermoFisher Scientific, Waltham, MA, USA) according to the manufac-
turer’s instructions. Ten micrograms of proteins were precipitated by incubation in 90%
acetonitrile for 30 min at 4 ◦C, followed by centrifugation for 10 min, at 4 ◦C, at 10,000× g.
The protein pellet was re-suspended in 50 mM ammonium bicarbonate and incubated
in: (i) 10 mM DTT (dithiothreitol) for 40 min at 56 ◦C, under stirring at 600 rpm (Ther-
momixer comfort, Eppendorf, Hamburg, Germany), to reduce disulfide bonds, (ii) 20 mM
iodoacetamide protected from light for 30 min, at room temperature, to alkylate/block
cysteine residues, (iii) 11 mM DTT protected from light for 10 min, at room temperature, to
quench the residual iodoacetamide, (iv) mass-spectrometry-grade trypsin (Pierce™ Trypsin
Protease, MS Grade, ThermoFisher Scientific, Waltham, MA, USA) at a 1:50 enzyme:protein
ratio (protein concentration = 0.25 µg.µL−1), for 18 h at 37 ◦C, under stirring at 600 rpm
(Thermomixer comfort, Eppendorf, Hamburg, Germany) and (v) MS-grade trypsin, at a
1:100 enzyme:protein ratio and acetonitrile to a final concentration of 80% (v/v), for 3 h at
37 ◦C, under stirring at 600 rpm (Thermomixer comfort, Eppendorf, Hamburg, Germany).
Digestion was stopped by adding TFA (trifluoroacetic acid) to a final concentration of 0.5%
(v/v). Samples were dried in a vacuum concentrator and re-suspended at 3.75 µg/20 µL
in 0.1% TFA. At this step, aliquots from each sample were collected and mixed in three
10-sample pools, considering three series of 10 individual samples and an average pooled
sample per series. Individual samples and pooled samples were desalted with C18 Zip
Tips (Pierce™ C18 Tips, ThermoFisher Scientific, Waltham, MA, USA) according to the
manufacturer’s recommendations, dried and re-suspended at 3 µg/9 µL (injection volume)
in 0.1% TFA spiked with an equivalent of MassPREP Digestion Standard Mixture 1 (MPDS
Mix 1, #186002865, Waters, Milford, MA, USA) corresponding to 50 fmol of ADH (alcohol
dehydrogenase 1 from Saccharomyces cerevisiae) content per injection volume.
2.3. Liquid Chromatography and Mass Spectrometry Data Acquisition
The individual samples and pooled samples were sorted into three series of ten
samples plus one pooled mix per series and analyzed using an ACQUITY UPLC M-Class
liquid chromatography system (Waters, Milford, MA, USA) coupled with a Q-Exactive
Plus Hybrid Quadrupole-Orbitrap mass spectrometer (ThermoFisher Scientific, Waltham,
MA, USA). Three acquisition rounds (1 per series) were performed to avoid any technical
bias that might come from a single LC–MS acquisition series.
The chromatographic separation consisted of a 3 min-long trapping step performed
on a reversed-phase (RP) ACQUITY UPLC M-Class Trap Column (nanoEase MZ Symmetry
C18 Trap Column, 100 Å, 5 µm, 180 µm × 20 mm, Waters, Milford, MA, USA) followed
by a 177 min elution step on an ACQUITY UPLC M-Class Analytical Column (nanoEase
MZ HSS T3 C18 Analytical Column, 100 Å, 1.8 µm, 75 µm × 250 mm, Waters, Milford,
MA, USA) using a gradient of mixed water and acetonitrile, both supplemented with 0.1%
formic acid, as eluents.
The mass acquisition was operated in data-dependent positive ion mode. Source
parameters were set at: (i) 2.3 kV for spray voltage, (ii) 270 ◦C for capillary temperature
and (iii) S-lens RF level = 50.0.
For individual samples, MS spectra were obtained for scans between m/z 400 and
m/z 1600 with a mass resolution of 70,000 at m/z 200, an Automated Gain Control (AGC)
of 3 × 106, a maximum Injection Time (IT) of 200 ms and an internal lock mass calibration
at m/z 445.12003. MS/MS spectra were obtained for the top 10 most intense ions of each
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MS scan (TopN = 10) with a mass resolution of 17.500 at m/z 200, an isolation window of
1.6 m/z with an isolation offset of 0.5 m/z, an AGC of 1 × 105, a maximum IT of 200 ms
and a (N)CE at 28. The exclusion of single-charged ions and a 10 s dynamic exclusion
were enabled.
For each pooled sample, the MS acquisition consisted of a two-step strategy of three
injections each. During both steps, MS spectra were obtained for scans between m/z 400
and m/z 528.3, m/z 524.3 and m/z 662.8 or m/z 658.8 and m/z 1600, in three independent
analyses, respectively, with a mass resolution of 70,000 at m/z 200, an AGC of 3 × 106, a
maximum IT of 200 ms and internal lock mass calibrations at m/z 445.12003, m/z 536.16537
and m/z 684.20295, respectively. During the first acquisition step, MS/MS spectra were
obtained for the top 25 most intense ions of each MS scan (TopN = 25) with a mass resolution
of 17.500 at m/z 200, an isolation window of 1.6 m/z with an isolation offset of 0.5 m/z, an
AGC of 1 × 105, a maximum IT of 250 ms and a (N)CE at 28. For the second acquisition
step, an exclusion list for all signals related to peptides identified at the first step with more
than 4 PSM (peptide-spectrum matches) was uploaded to the methods. During the second
acquisition step, MS/MS spectra were obtained for the top 10 most intense ions of each
MS scan (TopN = 10) with a mass resolution of 17.500 at m/z 200, an isolation window of
1.6 m/z with an isolation offset of 0.5 m/z, an AGC of 1 × 105, a maximum IT of 600 ms
and a (N)CE at 28. The exclusion of single-charged ions and a 15 s dynamic exclusion were
enabled for both steps.
2.4. Bioinformatic Analysis and Statistics
Raw MS data were submitted to protein identification and label-free quantification
by the MaxQuant software (version 1.6.6.0) using default settings when not specified
otherwise. Identification consisted of a search against a custom-made reviewed Uniprot
Homo sapiens database (20443 Homo sapiens entries + 4 MPDS Mix 1 entries, release date
8 August 2019) with carbamidomethyl (C) set as a fixed modification, oxidation (M) and
deamidation (NQ) set as variable modifications and a minimum of two peptides (including
one unique peptide) required. LFQ (label-free quantification) was enabled with a minimum
LFQ ratio count of 1, no Fast LFQ and no requirement of MS/MS for LFQ comparison. The
‘match between runs’ option was enabled and tuned to allow matches from the library
(pooled aliquots considered as parameter group 1, ‘match from’) and between individual
samples (parameter group 0, ‘match from and to’). A match time window of 2.5 min
was used.
MaxQuant output data (proteinGroups.txt) were submitted to statistical analysis
using the Perseus software (version 1.6.10.43). ‘Only identified by site’, ‘REVERSED’ and
contaminant data were filtered out. LFQ intensities were log2-transformed and proteins
with less than 50% of valid values were filtered out. Principal component analysis (PCA)
was performed on Z-score-normalized LFQ intensities. The male versus female comparison
was addressed by a two-sample Student’s t-test with a permutation-based FDR calculation.
Proteins with a fold change above 2 and an FDR below 0.05 were considered significantly
differently expressed between female and male groups. Heat-map representation and
hierarchical clustering were generated using the average Euclidian distance calculation.
PERMANOVA (PERmutational Multivariate ANalysis Of VAriance) tests were per-
formed with the PAST software (version 4.04) using the hierarchical clustering distance
matrix with the number of permutations set to 999.
The classification of identified proteins and over-representation/enrichment were
conducted using the online search engine powered by the PANTHER Classification system.
The PANTHER Overrepresentation test (release date 28 July 2020) parsed the PANTHER
database (version 10.5281/zenodo.4081749, release date 9 September 2020) using the Homo
sapiens reference list, the PANTHER-Gene Ontology-Slim and PANTHER Protein Class
annotation datasets. Only p < 0.05 items were retained and considered significantly over-
represented.
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Visualization of proteome overlaps was achieved by submitting SwissProt accession
numbers to the online Venn diagram generator Venny (version 2.1.0, https://bioinfogp.
cnb.csic.es/tools/venny, access date 10 November 2020).
Visualization of interaction networks was achieved by submitting SwissProt accession
numbers to STRING (version 11.0, https://string-db.org, access date 27 April 2021).
Due to the limited and variable sweat volume collected, together with the relatively
low and variable sweat protein concentration plus the need to store sweat samples for
further analyses, no technical replicate was performed. To account for technical variability,
sweat samples were processed and analyzed in three series of ten individual samples.
2.5. Subject Inclusion and Study Approval
All 30 sweat samples were collected at steady-state conditions from volunteers with
no known acute or chronic illness, no known drug use at the time of collection, no cosmetic
uses or skin damage at the site of collection and no clinical sign of dehydration. Subjects
were asked to fast and keep well hydrated over a minimum of 8 h before collection. Female
volunteers were neither pregnant nor lactating. The study was approved by the ethics
committee of Cliniques Universitaires Saint-Luc—Université Catholique de Louvain faculty
hospital (ClinicalTrials.gov identifier: NCT03993600). All subjects signed an informed
consent and were not enrolled in another clinical trial. A material transfer agreement was
signed with Université de Liège for sample analysis.
After sweat collection, sweat chloride (coulometry, ChloroChek chloridometer, ELITech-
Group, Brussels, Belgium), sodium and potassium concentrations (flame photometry, Flame
Photometer Model 420, Sherwood Scientific, Cambridge, UK) were measured. All samples
presented physiologically normal values.
3. Results
3.1. The Proteome of Human Eccrine Sweat
Individual eccrine sweat samples were analyzed separately to gain insight into their
individual proteome. To allow optimal protein identification, missing identifications (IDs)
from individual analysis were completed with IDs transferred from the analysis of both
other samples in the cohort and pooled aliquots thanks to the match between runs option
of the MaxQuant software (version 1.6.6.0) (Figure 1).
3.2. Protein Identification: Comparison to Previous Studies
Sweat samples from 30 healthy subjects—see Supplementary Table S1 for a complete
clinical data summary—were analyzed by nanoLC–MS/MS. Based on chromatogram
discrepancy, poor correlation with the other sample data and a low number of identified
proteins, two samples were discarded (Supplementary Figure S1)—clinical data related to
the 28 remaining samples are summed up in Table 1. Eventually, considering a minimum
of two peptides—including one unique peptide—and a False Discovery Rate (FDR) below
0.01 for protein identification, a total of 986 proteins were identified, accounting for data
filtering (Supplementary Table S2) and the standard protein mixture (MPDS Mix 1, Waters)
for quality control. A total of 535 ± 22 proteins were peptide-spectrum matching hits,
while 273 ± 9 proteins required matching between runs for identification for an average
total of 808 ± 16 proteins identified for each sample (Figure 2a). A total of 347 proteins
were consistently identified across all samples.




Figure 1. General experimental workflow. (a) Standardized sweat collection method. (b) Single sample preparation 
method for subsequent sweat proteomics and metabolomics studies. (c) Analytical and bioinformatic strategy using the 
“match between runs” option (MaxQuant). 1. Generation of a sweat reference proteome database from pooled samples. A 
two-round analysis of three limited m/z range acquisitions was performed. A precursor exclusion list was applied for the 
second round experiment. 2. Individual sweat sample analyses. (d) Statistical data processing tools. 
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19_2792 36 M 22.7 62.1 87.8 56 26 8 0.488 3.48 1.61 0.50 42.85
HV
(n = 28)
19_2796 29 M 31.6 48.1 42.4 23 4 10 0.557 1.11 0.19 0.48 23.62
19_2805 28 M 30.0 98.9 97.5 59 24 7 0.340 5.84 2.37 0.69 33.15
19_2812 40 M 25.5 89.6 96.5 39 18 8 0.432 3.49 1.61 0.72 41.69
19_2866 74 M 21.3 56.9 64.2 37 12 12 0.551 2.11 0.68 0.68 35.37
19_2823 31 F 19.8 71.8 89.8 32 10 10 0.262 2.30 0.72 0.72 23.53
19_2830 30 F 23.1 94.0 77.9 32 11 8 0.462 3.01 1.03 0.75 35.99
19_2843 24 F 18.2 63.5 64.1 65 36 10 0.472 4.13 2.29 0.64 30.26
19_2849 27 F 20.5 97.7 84.6 22 10 8 0.432 2.15 0.98 0.78 36.55
19_2856 29 F 18.7 79.7 70.4 28 6 8 0.422 2.23 0.48 0.64 29.71
19_3163 32 F 19.4 44.8 30.1 30 12 9 0.785 1.34 0.54 0.40 23.63
19_3166 26 F 18.9 57.2 64.0 44 22 10 0.494 2.52 1.26 0.57 31.62
20_1490 39 F 21.3 40.1 43.5 26 12 8 0.371 1.04 0.48 0.32 16.14
19_3177 28 M 23.1 35.9 27.0 51 30 8 0.475 1.83 1.08 0.29 12.83
19_3190 29 M 24.5 98.6 80.7 55 28 6 0.406 5.42 2.76 0.59 32.76
19_3194 41 M 24.1 34.4 42.7 36 8 9 0.736 1.24 0.28 0.31 31.43
19_3197 36 M 22.5 27.5 82.7 91 44 8 0.504 2.50 1.21 0.22 41.68
19_3207 28 M 23.8 84.9 93.2 45 22 7 0.364 3.82 1.87 0.59 33.92
20_1494 29 F 20.9 61.3 64.4 54 30 12 0.441 3.31 1.84 0.74 28.40
19_2869 28 F 17.7 57.1 45.9 67 10 24 0.646 3.83 0.57 1.37 29.65
19_2877 33 F 22.3 102.7 83.7 35 12 7 0.350 3.59 1.23 0.72 29.30
19_2882 24 F 20.6 57.2 53.6 29 10 6 0.377 1.66 0.57 0.34 20.21
19_3169 57 F 19.2 35.6 29.9 58 24 8 0.661 2.06 0.85 0.28 19.76
20_1479 25 M 24.5 56.4 72.6 69 38 7 0.336 3.89 2.14 0.39 24.39
20_1484 24 M 23.6 99.0 93.4 49 20 8 0.622 4.85 1.98 0.79 58.09
19_2817 26 M 20.8 47.4 40.4 73 44 9 0.314 3.46 2.09 0.43 12.69
19_3448 30 M 20.6 91.2 74.0 50 22 10 0.448 4.56 2.01 0.91 33.15






22.2 67.7 67.7 47 21 9 0.462 3.13 1.39 0.58 29.72
Median 29 21.8 61.7 71.5 47 21 8 0.445 3.16 1.22 0.59 29.98
SD 11 3.2 24.2 22.7 18 12 3 0.137 1.49 0.89 0.24 9.87
SEM 2 0.6 4.6 4.3 3 2 1 0.026 0.28 0.17 0.05 1.87
The optimization of sweat sample preparation and MS acquisition together with the
strategy for thorough protein identification significantly improved the analysis depth, as
shown by the comparison with earlier sweat proteomics reports (Figure 2b). In terms
of proteome coverage, the overall number of identified proteins was significantly higher
when compared to previous studies with similar workflows. In addition, the increase in
protein identification was characterized by an extended overlap with previously reported
proteomes. It is noteworthy that while those studies relied on the use of pooled sweat
samples to account for the limited volume available, the current work focused on the
analysis of individual samples, with similar or better performance in protein identification.
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Figure 2. Performance of sweat shotgun proteomics. (a) Number of proteins identified (min. 2 peptides, 1 unique peptide)
in each sample, by MS/MS (in light green) and by MbR (in purple), with total number of identified proteins (in orange).
Standard proteins (n = 3, MPDS Mix 1) were kept as quality control. (b) Protein identification overlap with previous sweat
proteomics studies (min. 2 unique peptides). Contaminant proteins were kept for proteome comparison. Here, the reference
proteome included 975 proteins of interest plus 3 standard proteins (MPDS Mix 1) and 22 contaminants, identified with a
m nimum of 2 unique peptides.
3.3. Protein Classification and Over-Representation
Identified sweat proteins were classified and tested for over-representation by the
PANTHER Classification system and Gene Ontology Enrichment analysis, mapping pro-
tein IDs against PANTHER GO Sli annotation datasets (Supplementary Tables S3–S6).
The sweat proteome was significantly enriched in: (i) proteins related to proteolytic ac-
tivity, proteases and peptidases [11] as well as their respective inhibitors, and (ii) protein
effectors and regulators of the innate and adaptive immune systems [10,13]. Moreover,
(i) cytoskeletal proteins, i.e., protein components (actin and ABP) of the actin cytoskeleton
and regulators of actin organization and dynamics, (ii) proteins of reactive oxygen species
metabolism and oxidative stress, (iii) markers of UPR and ER stress, (iv) components and
regulators of the proteasome or (v) proteins of all major metabolic pathways, were among
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the over-represented proteins mapped to annotation clusters. A rapid annotation of the
interaction network of sweat core proteins highlighted interaction clusters related to the
biological functions mentioned above (Figure 3).




Figure 3. Interaction network mapping of sweat core proteins (347 proteins in 28/28 samples). The 347 query proteins 
resulted in 337 mapped proteins. Network settings included: Homo sapiens database, highest confidence minimum re-
quired interaction score, hidden disconnected nodes and confidence-based networking.  
Figure 3. Interaction network mapping of sweat core proteins (347 proteins in 28/28 samples). The 347 query proteins
resulted in 337 mapped proteins. Network settings included: Homo sapiens database, highest confidence minimum required
interaction score, hidden disconnected nodes and confidence-based networking.
3.4. Relative Contributions of Plasma and the Eccrine Gland to Sweat Protein Composition
When comparing the 20 most abundant proteins of sweat (from the current study, 2.8%
of total sweat proteins) to the plas a proteome [19] (Figure 4a), only 13 sweat proteins
w re retriev d in plasma and 7 were exclusive t sweat. Conversely, when comparing the
20 most abundant proteins of plasma to the sweat proteome, only 11 plasma proteins were
retrieved in sweat, 9 being exclusive to plasma. Proteins exclusive to sweat, together with
the absence of proteins shared between the top 20 proteins of plasma and sweat, highlighted
the specificity of the sweat proteome. This observation excluded the filtration of plasma as
the sole contributor to sweat protein composition. On a side note, the covered dynamic
range of sweat was quite similar to that of plasma, spanning five orders of magnitude
(Figure 4b).
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abundance = % Log10 LFQ intensity of top 10. (b) Dynamic range of sweat compared to plasma. Most and least intense
proteins as well as ec rine gland markers in sweat were an otated. (c) Protein identification overlap ith plas a and
eccrine cel lysate (al identified proteins). onta inant proteins ere kept for proteo e co parison. ere, the reference
proteo e included 983 proteins of interest plus 3 standard proteins ( PDS ix 1) and 24 conta inants, identified ith a
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The overlap of proteins between the current work and earlier plasma and eccrine
gland proteomic reports was estimated so as to evaluate the different contributions to the
sweat proteome at a larger scale (Figure 4c). Comparison to plasma and eccrine gland
proteomes showed that 19.7% of sweat proteins were specific to sweat while 6.5% were
shared between sweat and plasma, 44.8% were shared between sweat and the eccrine gland
and 29% were shared between the three proteomes of interest.
Mapping proteins of different tissue origins to PANTHER-GO annotation clusters,
the over-representation test determined that: (i) proteins exclusive to the current sweat
proteome dataset were predominantly mapped to annotation clusters related to proteolytic
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activity and immune systems, (ii) proteins of plasma origin were mapped to annotation
clusters related to proteolytic activity, immune systems, oxidative stress, proteasome and
metabolic pathways, (iii) proteins originating from the eccrine gland were mapped to an-
notation clusters for proteolytic activity, actin organization and dynamics, proteasome and
metabolic pathways and (iv) proteins of mixed origins were mapped to annotation clusters
for proteolytic activity, actin dynamics, oxidative stress, UPR and ER stress, proteasome
and metabolic pathways (Supplementary Tables S7–S22).
In conclusion, sweat is not a transudate of plasma, due in part to the active input of
the eccrine gland in sweat protein composition.
3.5. Inter-Individual Variability of the Sweat Proteome
A total of 986 identified proteins were suitable for protein label-free quantification. For
further statistical analysis of protein abundances across samples, only those identified and
quantified in at least 50% of the samples (14 out of 28) were used, for a total of 873 proteins.
First, the combined biological and technical variability was estimated by calculating
the coefficients of variation (CV) of protein abundances measured across the 28 remaining
samples. The distribution of combined biological and technical CV was density-plotted
against the median log10-transformed protein abundance, as shown in Figure 5a. The
variability across sweat samples was higher than the variability across plasma samples [19]
and was on par with the variability across urine samples [20]. A total of 639 proteins had a
CV below 100%, of which 105 proteins had a CV below 50%.
Computation of Pearson’s correlation coefficients (PCC) and average Euclidian dis-
tance hierarchical clustering were used to classify samples according to profiles of pairwise
correlation with other samples in the cohort. Samples were sorted into nine distinctive
clusters of significant sample correlation, i.e., sweat proteome profiles according to the joint
observation of the clustering tree structure and the “heat” of PCC (Figure 5b). Available
clinical data (including age, gender, BMI plus collected sweat volumes, ion concentrations,
ion amounts, protein concentration and protein mass) were tested for their correlation with
the biological inter-individual variability of the sweat proteome.
First, numeric clinical data were color coded based on their relative position in the
quartile-delimitated distribution (Supplementary Table S23) to estimate if hierarchical
clustering had grouped samples with matching clinical parameters. Anthropometric
parameters such as age, gender and BMI did not appear as likely contributors to the
inter-individual variability of the sweat proteome, as clusters did not group samples
with matching age, gender or BMI. However, specific sweat-related parameters such as
collected sweat volume (water loss), ion molarities and ion amounts (ion loss) as well as
protein concentration and protein mass (protein loss) likely reflected the variability of sweat
proteome profiles, since hierarchical clustering grouped samples with matching levels of
water, ion or protein loss. In other words, variations in such sweat-related parameters
might translate to variations in sweat proteome profiles.
Then, anthropometric and sweat-related parameters were tested for the significance of
their correlation with the clusters of sample correlation by PERMANOVA (Figure 5b, lower
panel), which compared clinical data distribution to hierarchical clustering in an objective
way. As expected, no significant correlations between anthropometric parameters (age, sex
and BMI) and sweat proteome profiles were observed. Neither were significant correlations
between sweat-related parameters (right and left arm collected volumes, Na+, Cl− and
K+ concentrations, Cl− and K+ amounts and protein mass) and sweat proteome profiles.
Only secreted Na+ distribution stood out as significantly correlated with sweat proteome
profiles and was emphasized as a core byproduct of the inter-individual variability of the
sweat proteome.
To sum up, only the local sweat-related parameter, secreted Na+, but not anthropo-
metric parameters, was a significant marker of the biological inter-individual variability of
sweat protein composition, at steady-state conditions upon pilocarpine iontophoresis.
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3.6. Inter-Ge der Variability of the Sweat Proteome
Assessing the inter-gender variability of sweat proteins, the differential composi-
tion of male and female sweat proteomes was first estimated: 99.4% of sweat proteins
were shared between male and female volunteers. Of 986 identified proteins, only 4
proteins—catenin α-1 (2/13 female HV), glutathione S-transferase θ-2B (4/13 female HV),
immunoglobulin κ variable 2–28 (2/13 female HV) and leucine-rich repeat-containing
protein 15 (1/13 female HV)—were exclusive to female HV, and two proteins—prostate-
specific antigen (4/15 male HV), V-set and transmembrane domain-containing protein
2A (8/15 male HV)—were exclusive to male HV (Figure 6a). Furthermore, while princi-
pal component analysis between female and male samples did not indicate any gender-
related dispersion (Figure 6b), significant changes in protein abundance between male
and female sweat were observed for 3 out of 986 proteins (Figure 6c). Kallikrein-11
(log2 LFQ (Male − Female) = −2.43, p = 5.64 × 10−7, p < 0.001***, 28/28 HV) was signifi-
cantly more abundant in female sweat while prolactin-inducible peptide (log2 LFQ (M − F)
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= 1.97, p = 1.55 × 10−4, p < 0.001 ***, 28/28 HV) and signal peptide, CUB, EGF-like domain-
containing protein 2 (log2 LFQ (M − F) = 2.48, p = 9.77 × 10−7, p < 0.001 ***, 26/28 HV)
were significantly more abundant in male sweat (Figure 6d).
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4. iscussion
The current study was designed to run a thorough and in-depth characterization of
the eccrine sweat proteome of healthy subjects, at an individual level. This was achieved
with 983 sweat proteins (including 344 core proteins) identified and quantified by inter-
individual relative abundance, while previous results from published studies were obtained
through the analysis of pooled individual samples. A standardized and optimized work-
flow, from the sample collection and sample preparation to the LC–MS analysis and the
bio-informatics for data processing, was developed. Altogether, the present methods
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and results described above could be considered a reference for further personalized
monitoring studies.
Over the past decade, eight studies have focused on the proteomic profiling of sweat.
To do so, four different sweat collection strategies were tested: (i) pharmacological cholin-
ergic stimulation by pilocarpine iontophoresis, at a volar forearm site, and collection using
the Macroduct system [14,15], (ii) heat stimulation and collection [10], (iii) stimulation by
physical exercise and collection using absorbing tissue pads at multiple body sites [11] and
(iv) stimulation by physical exercise and collection with the Macroduct system [12,13].
All studies opting for Macroduct collection resulted in a low depth of proteome
coverage regardless of the stimulation method. Such a low yield can be explained by low
collected volumes, given that, in the present work, sweat volumes two to three times larger
than those reported in previous studies (collected over the same 30 min interval) resulted
in a five to twenty times larger number of identified proteins (in the same conditions
of stringency). Interestingly, before the present study, the largest reported number of
identified proteins was obtained by doubling the duration of Macroduct collection [13].
The importance of sweat was confirmed when Yu et al. [11] chose a different collection
method, using absorbing tissue pads at different body sites to collect larger volumes.
However, it is noteworthy that the increase in the collected volume of sweat was hindered
by the greater probability of skin protein contamination.
By following gold standard consensus guidelines for sweat testing [18], the current
work ensured highly standardized and reproducible sweat stimulation, sampling and han-
dling, under spectroscopically pure conditions, preventing issues related to contamination
and sweat evaporation. On top of these recommendations, the collection from fasting,
well-hydrated, healthy subjects set a steady state for variations in biological origin, and
limited protein identification and quantitation biases. For the first time, standardized re-
producible sweat samples from healthy subjects were individually analyzed by optimized,
reproducible shotgun proteomics with high-resolution LC–MS/MS acquisition. Therefore,
the current study achieved the most thorough characterization of the eccrine sweat pro-
teome to date, setting references for protein composition and individual proteome profiles
of eccrine sweat.
The earliest reports of sweat proteomics already described a significant over-representation
of proteolysis markers, together with markers of the immune system [10,11]. In line with
the role of sweat in skin homeostasis and defenses, these results highlight an extended set
of proteases, peptidases and their inhibitors regulating the metabolism of anti-microbial
peptides in the broader context of skin innate immunity [21–24]. Protein families newly
described in the context of sweat, such as cytoskeleton, oxidative stress, UPR and ER stress,
proteasome and metabolism proteins, indicated a far more complex bio-fluid in terms of
the diversity of biological functions. This diversity can be explained by the presence of cell
exosomes in sweat [25].
The comparison between sweat, eccrine glands and plasma proteomes helped precise
tissue contributions in terms of protein numbers and biological functions. First, the current
work confirmed sweat did not result from the passive transport from plasma through the
eccrine gland cells. Both plasma and eccrine gland cells contribute to the sweat proteome, as
shown by proteins of plasma, eccrine or plasma/eccrine origins. Moreover, the contribution
of the eccrine gland proteome seemed the most dominant.
As discussed above, the depth of proteome coverage helped focus on non-described
sweat protein functions. The comparison to plasma and eccrine gland proteomes showed
that the diversity of biological functions of proteins from a given origin did not reflect the
diversity of biological functions of sweat proteins as a whole. For instance, proteins related
to actin dynamics preferentially came from eccrine gland cells, while immune system
proteins preferentially originated from plasma.
A significant part of the sweat proteins was not of plasma or eccrine origin. Other
sources of proteins could be exosomes of non-eccrine cells and immune system cells or
protein contamination from corneocytes at the collection site, despite the fact that a far
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less contamination-prone collection method was chosen. It is noteworthy that shotgun
proteomics studies are not exhaustive in terms of proteome comprehension, by nature, so,
our knowledge of sweat protein origins is bound to evolve with more thorough studies
to come.
Beyond the need for a more in-depth coverage of the sweat proteome, the current
work aimed at a better understanding of the inter-individual variability of sweat proteome
profiles. In the context of heat acclimation and aerobic-exercise-related conditions, an-
thropometric parameters such as age, sex and body mass index were identified as notable
sources of the intra- and inter-individual variability of sweat secretion [16,17], e.g., the onset
and rate of sweating, with little evidence of age-, sex- or BMI-modified sweat composition.
Sweat rate was described as the main contributor to the variability of sweat composition,
and all age, sex or BMI effects on sweat composition were byproducts, i.e., sweat rate effects
beforehand. Therefore, for example, Na+ and Cl- sweat concentrations directly correlated
with sweat rate.
Sweat protein composition was correlated with sweat rate, as protein content increased
with increasing sweat rate, in heat acclimation experiments [26]. At steady-state conditions,
upon pharmacological sweat stimulation (pilocarpine iontophoresis), the present study
confirmed observations from heat acclimation and aerobic exercise: at steady state, (i) the
anthropometric parameters age, sex and BMI did not contribute to the inter-individual
variability of the sweat proteome, and (ii) sweat-rate-related parameters and sweat com-
position were correlated with the inter-individual variability of the sweat proteome, Na+
secretion being the main variable of interest.
The importance of gender must be discussed further. Conflicting reports about
the inter-gender variability of the sweat proteome have arisen in the past few years.
Yu et al. [11] concluded that gender-specific biomarkers were found in sweat, while Harsh-
man et al. [12] determined that male and female sweat were similar in terms of protein
composition. Although gender did not influence the inter-individual variability of the
sweat proteome as a whole, it appeared there were minor gender-related differences, high-
lighted by a few gender-specific differential protein abundances. These results reconcile
previous reports [11,12], since limited gender-specific biomarkers seem to exist despite a
near complete similarity.
In conclusion, standardized sample collection coupled with optimized shotgun pro-
teomics significantly improved the depth of sweat proteome coverage, far beyond previous
similar studies. Addressing the inter-individual variability of the sweat proteome, our
results demonstrate the proteomic profiling of sweat to be a promising lead in the search
for non-invasive, individualized monitoring of protein biomarkers in relation to biometric
tracking, clinical follow-up and personalized medicine. In this regard, investigators should
pay particular attention to inter-individual variations in sweating rate.
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